1350 J. Chin. Chem. Soc., Vol. 51, No. 6, 2004
Khalafy et al.
ethanol to give the desired product (2.51 g, 85%) as colourless
crystals m.p. 100-102 ºC. Anal. Calc for C12H11BrN2O4.H2S:
C, 41.73; H, 3.19; N, 8.11%; found: C, 41.87; H, 3.22; N,
1.34 Hz), 7.39 (t, 1H, J = 1.92 Hz), 7.44 (td, 1H, J1 = 7.64 Hz,
J2 = 1.29 Hz), 7.69 (dd, 1H, J1 = 8.15 Hz, J2 = 0.96 Hz), 7.79
(dt, 1H, J1 = 7.8 Hz, J2 = 0.97 Hz), 10.17 (s, 1H, NH). 13C
NMR d 14.31, 61.17, 79.20, 121.03, 121.63, 122.63, 122.99,
125.74, 126.04, 127.10, 129.51, 130.38, 133.35, 138.02,
149.10, 157.07, 161.23, 163.02, 163.81. FT-IR umax 3206,
1775, 1712, 1572, 1475, 1441, 1381, 1227, 1178, 1051, 956,
766 cm-1; MS m/z (%) 461 (M+, 12%), 459 (M+, 11%), 417
(82), 415 (71), 371 (48), 369 (40), 334 (25), 294 (28), 291
(27), 290 (100), 262 (30), 224 (27), 177 (33), 161 (34), 150
(40), 135 (26), 134 (33), 108 (29), 44 (65) and HRMS m/z
458.98883 (C19H14BrN3O4S requires 458.98884).
1
8.18%. H NMR (D6-DMSO+CDCl3) d 1.38 (t, 3H, J = 7.1
Hz), 4.37 (q, 2H, J = 7.1 Hz), 6.15 (bs, 1H, NH), 7.23 (dt, 1H,
J1 = 8.2 Hz, J2 = 1.8 Hz), 7.28 (t, 1H, J = 7.8 Hz), 7.33 (dt, 1H,
J1 = 7.8 Hz, J2 = 1.6 Hz), 7.51 (t, 1H, J = 1.8 Hz), 9.38 (bs, 1H,
NH),13C NMR(D6-DMSO+CDCl3) d 14.49, 60.26, 75.21,
119.80, 122.92, 123.82, 128.24, 130.95, 137.58, 162.85,
165.37, 166.72. FT-IR umax 3512, 3297, 1710, 1701, 1590,
1478, 1413, 1323, 1203, 1116, 1011, 794, 734 cm-1; MS m/z
(%) 328 (M+, 66%), 326 (M+, 68%), 282 (81), 280 (70), 201
(26), 197 (16), 171 (26), 157 (36), 91 (31), 90 (32), 76 (21),
63 (24), 45 (19), 44 (100), 40 (47), 36 (23) and HRMS m/z
325.99021 (C12H11BrN2O4 requires 325.99022).
Ethyl 2-(benzothiazol-2-yl)-3-(3-methylphenyl)amino-5-
oxo-2,5-dihydro-4-carboxylate (12, R=Me)
This compound was prepared as described above, using
the corresponding isoxazolone (11, R=Me) (70 mg, 0.27
mmol) and 2-chlorobenzothiazole (45.8 mg, 0.27 mmol) to
give the desired product as white prisms (50 mg, 50%) after
recrystalization from ethanol, m.p. 159-161 ºC. Anal. Calc
for C20H17N3O4S: C, 60.74, H, 4.33, N, 10.62%; found: C,
60.49; H, 4.14; N, 10.93%. 1H NMR d 1.3 (t, 3H, J = 7.1 Hz),
2.19 (s, 3H), 4.28 (q, 2H, J = 7.1 Hz), 6.85 (bd, 1H, J = 7.47
Hz), 6.98 (bd, 1H, J = 8.1 Hz), 7.00 (bs, 1H), 7.08 (t, 1H, J =
7.6 Hz), 7.36 (td, 1H, J1 = 8.1 Hz, J2 = 0.94 Hz), 7.42 (td, 1H,
J1 = 7.6 Hz, J2 = 0.85 Hz), 7.69 (bd, 1H, J = 8 Hz), 7.77 (dd,
1H, J1 = 7.9 Hz, J2 = 0.65 Hz), 10.07 (s, exchanged by D2O
addition, 1H, NH). 13C NMR d 14.31, 21.11, 60.95, 78.64,
119.63, 121.57, 123.09, 123.23, 125.97, 126.94, 127.33,
129.01, 133.67, 136.44, 139.30, 149.18, 157.33, 161.87,
Ethyl 3-(3-methylphenyl)amino-5-oxo-2,5-dihydroiso-
xazol-4-carboxylate (11, R=Me)
The compound was prepared as described above using
diethyl (3-methylphenyl)thiocarbamoylmalonate (1.1 g, 3.5
mmol) and refluxing for 24 h to give the desired product as
colourless crystals (0.7 g,75%), m.p. 109-111 ºC. 1H NMR
(D6-DMSO+CDCl3) d 1.38 (t, 3H, J = 7.1 Hz), 2.37 (s, 3H),
4.35 (q, 2H, J = 7.1 Hz), 7.02 (bd, 1H, J = 7.6 Hz), 7.07 (bd,
1H, J = 7.9 Hz), 7.1 (bs, 1H), 7.27 (t, 1H, J = 7.8 Hz), 9.31 (s,
1H, NH). 13C NMR (D6-DMSO+CDCl3) d 14.53, 21.34,
60.17, 74.82, 118.19, 121.82, 126.42, 129.47, 135.90,
139.75, 163.35, 165.64, 166.66. FT-IR u
3519, 3316,
max
1710, 1678, 1578, 1324, 1226, 1169, 1113, 1000, 795, 725
cm-1.
163.49. FT-IR u
3204, 1774, 1705, 1576, 1514, 1443,
max
Ethyl 2-(benzothiazol-2-yl)-3-(3-bromophenyl)amino-5-
oxo-2,5-dihydro-4-carboxylate (12, R=Br)
1382,1232, 958, 767 cm-1.
Ethyl 3-(3-bromophenyl)amino-5-oxo-2,5-dihydroiso-
xazol-4-carboxylate (100 mg, 0.3 mmol) and 2-chlorobenzo-
thiazole (51 mg, 0.3 mmol) were refluxed in chloroform or
toluene (5 mL) for 48 h. The solvent was removed under re-
duced pressure. On addition of n-hexane (10 mL) to the resi-
due (colourless oil) a white precipitate was formed. The pre-
cipitate was filtered and recrystallized from ethanol to give
ethyl 2-(benzothiazol-2-yl)-3-(3-bromophenyl)amino-5-oxo-
2,5-dihydro-4-carboxylate as white prisms (84.4 mg, 60%)
m.p. 153-155 ºC. Anal. Calc for C19H14BrN3O4S: C, 49.56, H,
3.04, N, 9.13%; found: C, 49.56; H, 2.71; N, 9.02%. 1H NMR
d 1.32 (t, 3H, J = 7.1 Hz), 4.30 (q, 2H, J = 7.1 Hz), 7.08 (t, 1H,
J = 7.9 Hz), 7.14 (dt, 1H, J1 = 8.65 Hz, J2 = 1.59 Hz), 7.20 (dt,
1H, J1 = 7.79 Hz, J2 = 1.55 Hz), 7.38 (td, 1H, J1 = 7.6 Hz, J2 =
Ethyl 2-(benzothiazol-2-yl)-3-(phenyl)amino-5-oxo-2,5-
dihydro-4-carboxylate (12, R=H)
This compound was prepared as described above, using
the corresponding isoxazolone (11, R=H)7 (100 mg, 0.4
mmol) and 2-chlorobenzothiazole (67.85 mg, 0.4 mmol) to
give the desired product as white prisms (100 mg, 65%) after
recrystalization from ethanol, m.p. 141-142 ºC. Anal. Calc
for C19H15N3O4S: C, 59.83, H, 3.96, N, 11.02%; found: C,
60.00; H, 3.72; N, 11.05%. 1H NMR d 1.29 (t, 3H, J = 7.1 Hz),
4.27 (q, 2H, J = 7.1 Hz), 7.04-7.08 (m, 1H), 7.18-7.23 (m,
4H), 7.35 (td, 1H, J1 = 7.6 Hz, J2 = 1.3 Hz), 7.40 (td, 1H, J1 =
7.6 Hz, J2 = 1.3 Hz), 7.65 (dd, 1H, J1 = 7.9 Hz, J2 = 0.88 Hz),
7.76 (dd, 1H, J1 = 7.75 Hz, J2 = 1 Hz), 10.15 (s, exchanged by
D2O addition, 1H, NH). 13C NMR d 14.30, 60.97, 78.72,